Loading...
Development of an engineered peptide antagonist against periostin to overcome doxorubicin resistance in breast cancer
BACKGROUND: Chemoresistance is one of the main problems in treatment of cancer. Periostin (PN) is a stromal protein which is mostly secreted from cancer associated fibroblasts in the tumor microenvironment and can promote cancer progression including cell survival, metastasis, and chemoresistance. T...
Na minha lista:
| Udgivet i: | BMC Cancer |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7807878/ https://ncbi.nlm.nih.gov/pubmed/33446140 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07761-w |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|